CARL - CARLSMED, INC.

QQQ $ 585.96 $ -25.71 (-4.2 %)

DIA $ 458.31 $ -8.37 (-1.79 %)

SPY $ 653.03 $ -19.87 (-2.95 %)

TLT $ 89.29 $ 0.30 (0.33 %)

GLD $ 374.78 $ -0.40 (-0.11 %)

Previous Close

$ 11.84

Open

$ 11.95

Bid

$ 11.83 x 200

Ask

$ 11.88 x 10

Day's Range

$ 11.83 - $ 12.23

52 Week Range

$ 11.70 - $ 16.20

Volume

60,646

Average Volume

Market Cap

249.6M

Beta (5Y Monthly)

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na (nm)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
1	11-06-2025	09-30-2025	10-Q
2	08-28-2025	06-30-2025	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Truist Securities Reiterates Buy on Carlsm...
11/07/2025 15:49:03

Truist Securities analyst Richard Newitter reiterates Carlsmed (NASDAQ:CARL) with a Buy and raises the price target from $18...

BTIG Maintains Buy on Carlsmed, Raises Pri...
11/07/2025 09:29:23

BTIG analyst Ryan Zimmerman maintains Carlsmed (NASDAQ:CARL) with a Buy and raises the price target from $21 to $24.

Carlsmed Raises FY2025 Sales Guidance from...
11/06/2025 21:12:27

Carlsmed (NASDAQ:CARL) raises FY2025 sales outlook from $45.500 million-$47.500 million to $49.000 million-$50.000 million vs $...

Carlsmed Q3 EPS $(0.40), Inline, Sales $13...
11/06/2025 21:01:54

Carlsmed (NASDAQ:CARL) reported quarterly losses of $(0.40) per share which met the analyst consensus estimate. This is a 80.58...

Earnings Scheduled For November 6, 2025
11/06/2025 11:12:19

Carlsmed, Inc. Added To Russell 2000, Effe...
09/22/2025 13:04:24

Carlsmed Sees FY2025 Sales $45.500M-$47.50...
08/28/2025 20:15:29

Carlsmed Q2 EPS $(1.47) Misses $(1.15) Est...
08/28/2025 20:13:48

Earnings Scheduled For August 28, 2025
08/28/2025 08:32:14

carlsmeds-personalized-spine-implants-get-significant-reimbursement-advantage

Carlsmed's Personalized Spine Implants Get...
08/18/2025 18:25:42

Carlsmed secures NTAP reimbursement and FDA support, while BofA projects strong revenue growth and assigns a Buy rating with a ...

Truist Securities Initiates Coverage On Ca...
08/18/2025 14:34:09

Truist Securities analyst Richard Newitter initiates coverage on Carlsmed (NASDAQ:CARL) with a Buy rating and announces Pric...

this-synaptics-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-monday

This Synaptics Analyst Begins Coverage On ...
08/18/2025 13:09:45

Goldman Sachs Initiates Coverage On Carlsm...
08/18/2025 11:25:56

Goldman Sachs analyst David Roman initiates coverage on Carlsmed (NASDAQ:CARL) with a Buy rating and announces Price Target ...

Piper Sandler Initiates Coverage On Carlsm...
08/18/2025 10:31:26

Piper Sandler analyst Matt O'Brien initiates coverage on Carlsmed (NASDAQ:CARL) with a Overweight rating and announces P...

Carlsmed's Aprevo Implants Receive CMS NTA...
08/01/2025 13:07:24

Carlsmed, Inc. ("Carlsmed"), a medical technology company pioneering AI-enabled personalized spine surgery solutions, t...

Carlsmed Announces First Successful AI-Ena...
07/28/2025 13:10:07

Carlsmed, Inc. (NASDAQ:CARL) ("Carlsmed"), a medical technology company pioneering AI-enabled personalized spine surger...

Carlsmed IPO Indicating $15.53/Share On 16...
07/23/2025 15:07:28

Carlsmed IPO Indicating $20/Share On 132K ...
07/23/2025 14:34:36

Trading Halt: Halt status updated at 10:10...
07/23/2025 14:10:07

Reported Earlier, Carlsmed Prices $100.5M ...
07/23/2025 07:17:51

The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payab...